PET/CT helps predict survival in patients with breast cancer

03/11/2012 | MolecularImaging.net

Changes in 18F-FDG PET/CT standard uptake value measured before and again three months after selective internal radiation therapy can help predict survival in patients who have hepatic metastases due to breast cancer, according to a study in the Journal of Nuclear Medicine. Patients who responded to radioembolization survived longer than those who didn't, the study found.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA